argonautms.com
How to Get Ahead in the NGS Service Lab Market - Argonaut Manufacturing
The sequencing service lab market is hot right now, with over 75,000 genetic tests already available and a predicted clinical sequencing market value of $7.7 billion by 2020. Rising maturity of analysis techniques coupled with decreasing sequencing costs has led to an explosion of companies competing to reveal your genetic markers or whole genome. As pressures mount on existing service labs, new challengers will need to scale quickly with differentiated offerings. With competition rising, your lab will face several hurdles: Producing test results faster, either by process improvements or STAT-model adoption. Maximizing employee and workspace efficiency. Continuing R&D innovation without diverting resources to the testing lab. Learn more about these emerging challenges, and how one supply chain decision can help you get ahead in the NGS service lab market. Get Faster Turnaround Times in Your Lab Turnaround times are a powerful competitive differentiator, whether you perform laboratory developed tests (LDTs) or consumer genomics services. The American Association for Clinical Chemistry (AACC) predicts that as more targeted therapeutics are released, demand for clinical NGS will grow and shift labs towards a STAT model, where high-priority tests are performed immediately rather than in batches. This rapid processing and turnaround can significantly improve patient care when hours matter. A shift to STAT will result in CLIA lab employees losing the advantage of prepping reagents in bulk, instead requiring small volume preps multiple times per day. This repetitive reagent prep cuts into valuable turnaround time or requires a second technician working in parallel. While adopting …